December 3, 2019
Shionogi on December 2 rolled out an AI-powered drug information chatbot to respond to inquiries on its anti-influenza drug Xofluza (baloxavir marboxil) from medical professionals. The chatbot, named “DI chat,” was developed by Saga-based IT firm Kimura Information Technology by...read more